On June 30, 2023, a jury in the Northern District of California found Gilead and Teva not liable in a trial accusing the companies of engaging in an illegal reverse payment to delay generic versions of two HIV drugs, Truvada...more
7/6/2023
/ Anti-Competitive ,
Antitrust Litigation ,
Antitrust Violations ,
Generic Drugs ,
HIV ,
Patents ,
Pay-For-Delay ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Prescription Drugs ,
Reverse Payments
In the field of antitrust, the current COVID-19 pandemic poses unprecedented challenges for merging parties and agencies worldwide. As the crisis unfolds, enforcement against cartels, investigations of excessive pricing, and...more
3/23/2020
/ Antitrust Investigations ,
Antitrust Violations ,
Collaboration ,
Coronavirus/COVID-19 ,
Department of Justice (DOJ) ,
Electronic Filing ,
EU ,
European Commission ,
Excessive Pricing ,
Federal Trade Commission (FTC) ,
France ,
Germany ,
Mergers ,
Pre-Merger Filing Requirements ,
Regulatory Oversight ,
UK